Published in

Taylor and Francis Group, Expert Opinion on Pharmacotherapy, 18(21), p. 2317-2324, 2020

DOI: 10.1080/14656566.2020.1810237

Links

Tools

Export citation

Search in Google Scholar

Use of octreotide long acting repeatable (LAR) as second-line therapy in advanced neuroendocrine tumors in different clinical settings: an Italian Delphi survey

Journal article published in 2020 by Massimo Falconi ORCID, Nicola Fazio ORCID, Diego Ferone ORCID, Annibale Versari ORCID
Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO